Trademark: 97176335
Word
ZUFRELCI
Status Date
Wednesday, May 22, 2024
Filing Date
Thursday, December 16, 2021
Published for Opposition
Tuesday, October 25, 2022
5 Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; anti-allergics; anti-infectives
Dec 20, 2021
New Application Entered
Dec 21, 2021
New Application Office Supplied Data Entered
Sep 12, 2022
Assigned To Examiner
Sep 19, 2022
Approved For Pub - Principal Register
Oct 5, 2022
Notification Of Notice Of Publication E-Mailed
Oct 25, 2022
Published For Opposition
Oct 25, 2022
Official Gazette Publication Confirmation E-Mailed
Dec 20, 2022
Noa E-Mailed - Sou Required From Applicant
Dec 9, 2023
Notice Of Approval Of Extension Request E-Mailed
May 25, 2023
Sou Teas Extension Received
May 25, 2023
Sou Extension 1 Filed
May 25, 2023
Sou Extension 1 Granted
May 27, 2023
Notice Of Approval Of Extension Request E-Mailed
Dec 7, 2023
Sou Teas Extension Received
Dec 7, 2023
Sou Extension 2 Filed
Dec 7, 2023
Sou Extension 2 Granted
May 22, 2024
Sou Teas Extension Received
May 22, 2024
Sou Extension 3 Granted
May 22, 2024
Sou Extension 3 Filed
May 23, 2024
Notice Of Approval Of Extension Request E-Mailed
Trademark Alertz updated from USPTO on 2030-01-24
